Clinical trial
Effect of Palivizumab Treatment on Subsequent Recurrent Wheezing in Preterm Infants: Case-control Study by Scientific Committee of Recurrent Wheezing (SCREW)
NCT01072552 is registered in ClinicalTrials.gov with Satoshi Kusuda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Palivizumab Treatment on Subsequent Recurrent Wheezing in Preterm Infants: Case-control Study by Scientific Committee of Recurrent Wheezing (SCREW)
- Lead sponsor
- Satoshi Kusuda
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- August 31, 2011
- Enrollment
- 444 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
asthma, recurrent wheezing, wheezing